East Cobb Psychiatry LLC
At East Cobb Psychiatry LLC, patient safety, ethical prescribing, and regulatory compliance are our highest priorities. Certain psychiatric and addiction treatment medications—such as stimulants for ADHD/ADD (e.g., Adderall, Vyvanse, Ritalin), benzodiazepines (e.g., Xanax, Klonopin, Ativan), and Suboxone (buprenorphine–naloxone)—are classified as controlled substances under federal and state law. These medications can be highly effective when used appropriately but carry risks of misuse, dependence, and diversion.
1. Documentation and Diagnostic Verification
Before any controlled medication is prescribed:
- Patients must provide previous medical or psychiatric records supporting their diagnosis and prior treatment history.
- For Suboxone or other addiction-related treatments, documentation of prior treatment, urine drug screen results, and history of opioid use may be required.
- If transferring care, records from the previous provider or treatment program are needed before medication continuation.
- Additional diagnostic evaluations or lab testing may be requested to confirm medical necessity.
2. Safe and Ethical Prescribing
- Controlled substances are prescribed only when clinically indicated and after a comprehensive psychiatric and medical assessment.
- Prescriptions will not be replaced if lost, stolen, or misplaced.
- Early refills are not allowed unless approved under exceptional circumstances.
- East Cobb Psychiatry LLC does not provide same-day refills for new patients or for those without supporting documentation.
- All prescriptions comply with federal and Georgia state regulations, including DEA and PDMP monitoring requirements.
3. Monitoring and Drug Screening
To ensure safety, adherence, and compliance:
- Periodic Urine Drug Screens (UDS) may be required prior to and during treatment with any controlled medication.
- The Georgia Prescription Drug Monitoring Program (PDMP) is reviewed regularly to monitor prescription history.
- Patients may be required to bring all active medication bottles to appointments for review and reconciliation.
4. Treatment Agreements
- Patients prescribed controlled substances must sign a Controlled Substance Agreement outlining proper use, storage, and monitoring expectations.
- For Suboxone or other opioid treatment medications, a Medication-Assisted Treatment (MAT) Agreement may also be required.
- Violation of these agreements—including evidence of medication misuse, diversion, or inconsistent drug screens—may result in discontinuation of controlled medication prescriptions and possible discharge from the practice.
5. Follow-Up and Continuity of Care
- Regular follow-up appointments are required—typically every 30 to 90 days, depending on medication type and stability.
- Refills are issued only during scheduled visits.
- Telepsychiatry visits involving controlled substances must comply with federal telemedicine prescribing regulations and Georgia Composite Medical Board guidelines.
Note:
This policy reflects our commitment to safe, ethical, and evidence-based care for all patients receiving controlled medications, including stimulants, benzodiazepines, and Suboxone. Our goal is to promote recovery, stability, and patient well-being while maintaining compliance with all federal and state laws.